302 related articles for article (PubMed ID: 32832495)
1. Neuroendocrine liver metastases: a contemporary review of treatment strategies.
Cloyd JM; Ejaz A; Konda B; Makary MS; Pawlik TM
Hepatobiliary Surg Nutr; 2020 Aug; 9(4):440-451. PubMed ID: 32832495
[TBL] [Abstract][Full Text] [Related]
2. Surgical management of pancreatic neuroendocrine liver metastases.
Cloyd JM; Wiseman JT; Pawlik TM
J Gastrointest Oncol; 2020 Jun; 11(3):590-600. PubMed ID: 32655938
[TBL] [Abstract][Full Text] [Related]
3. Liver-Directed Locoregional Therapies for Neuroendocrine Liver Metastases: Recent Advances and Management.
Criss CR; Makary MS
Curr Oncol; 2024 Apr; 31(4):2076-2091. PubMed ID: 38668057
[TBL] [Abstract][Full Text] [Related]
4. [Liver metastases of neuroendocrine tumors].
Nadalin S; Peters M; Königsrainer A
Chirurgie (Heidelb); 2022 Jul; 93(7):659-666. PubMed ID: 35713676
[TBL] [Abstract][Full Text] [Related]
5. Hepatic surgery for metastases from neuroendocrine tumors.
Sarmiento JM; Que FG
Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
[TBL] [Abstract][Full Text] [Related]
6. Primary Tumor Site Affects Survival in Patients with Gastroenteropancreatic and Neuroendocrine Liver Metastases.
Tierney JF; Poirier J; Chivukula S; Pappas SG; Hertl M; Schadde E; Keutgen X
Int J Endocrinol; 2019; 2019():9871319. PubMed ID: 30992703
[TBL] [Abstract][Full Text] [Related]
7. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM
J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719
[TBL] [Abstract][Full Text] [Related]
8. Is there still a role for the hepatic locoregional treatment of metastatic neuroendocrine tumors in the era of systemic targeted therapies?
Cavalcoli F; Rausa E; Conte D; Nicolini AF; Massironi S
World J Gastroenterol; 2017 Apr; 23(15):2640-2650. PubMed ID: 28487601
[TBL] [Abstract][Full Text] [Related]
9. New and emerging systemic therapy options for well-differentiated gastroenteropancreatic neuroendocrine tumors.
Scoville SD; Cloyd JM; Pawlik TM
Expert Opin Pharmacother; 2020 Feb; 21(2):183-191. PubMed ID: 31760823
[No Abstract] [Full Text] [Related]
10. The Evolving Role of Radioembolization in the Treatment of Neuroendocrine Liver Metastases.
Ramdhani K; Braat AJAT
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884479
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of targeted therapies for advanced well-differentiated gastroenteropancreatic neuroendocrine tumors.
Cloyd JM; Konda B; Shah MH; Pawlik TM
Expert Rev Clin Pharmacol; 2019 Feb; 12(2):101-108. PubMed ID: 30582383
[TBL] [Abstract][Full Text] [Related]
12. Local therapies for hepatic metastases.
Johnston FM; Mavros MN; Herman JM; Pawlik TM
J Natl Compr Canc Netw; 2013 Feb; 11(2):153-60. PubMed ID: 23411382
[TBL] [Abstract][Full Text] [Related]
13. Metastatic disease to the liver: Locoregional therapy strategies and outcomes.
Zane KE; Cloyd JM; Mumtaz KS; Wadhwa V; Makary MS
World J Clin Oncol; 2021 Sep; 12(9):725-745. PubMed ID: 34631439
[TBL] [Abstract][Full Text] [Related]
14. Currently available treatment options for neuroendocrine liver metastases.
Machairas N; Daskalakis K; Felekouras E; Alexandraki KI; Kaltsas G; Sotiropoulos GC
Ann Gastroenterol; 2021; 34(2):130-141. PubMed ID: 33654350
[TBL] [Abstract][Full Text] [Related]
15. One stage surgery for synchronous liver metastasis from a neuroendocrine tumor of the colon. A case report.
Tartaglia N; Di Lascia A; Cianci P; Fersini A; Sanguedolce F; Iadarola R; Capuzzolo S; Neri V; Ambrosi A
Ann Ital Chir; 2017 Nov; 6():. PubMed ID: 29176078
[TBL] [Abstract][Full Text] [Related]
16. Contemporary indications for and outcomes of hepatic resection for neuroendocrine liver metastases.
Scoville SD; Xourafas D; Ejaz AM; Tsung A; Pawlik T; Cloyd JM
World J Gastrointest Surg; 2020 Apr; 12(4):159-170. PubMed ID: 32426095
[TBL] [Abstract][Full Text] [Related]
17. Surgery, Liver Directed Therapy and Peptide Receptor Radionuclide Therapy for Pancreatic Neuroendocrine Tumor Liver Metastases.
Ngongoni R; Visser B
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291892
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes following 90Y Radioembolization of neuroendocrine liver metastases: evaluation of the radiation-emitting SIR-spheres in non-resectable liver tumor (RESiN) registry.
Wong TY; Zhang KS; Gandhi RT; Collins ZS; O'Hara R; Wang EA; Vaheesan K; Matsuoka L; Sze DY; Kennedy AS; Brown DB
BMC Cancer; 2022 Mar; 22(1):224. PubMed ID: 35232410
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies for neuroendocrine liver metastases.
Frilling A; Clift AK
Cancer; 2015 Apr; 121(8):1172-86. PubMed ID: 25274401
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.
Spolverato G; Bagante F; Aldrighetti L; Poultsides G; Bauer TW; Field RC; Marques HP; Weiss M; Maithel SK; Pawlik TM
J Gastrointest Surg; 2017 Dec; 21(12):2039-2047. PubMed ID: 28744737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
